Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma

Experimental Lung Research

Volumn 34, Issue 8, 2008, Pages 501-511

  Olmez, Duygu ^a   Babayigit, Arzu ^a   Uzuner, Nevin ^a   Erbil, Guven ^a   Karaman, Ozkan ^a   Yilmaz, Osman ^a   Cetin, Emel Oyku ^b   Ozogul, Candan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Chronic asthma; Mice; Sulphasalazine; Treatment

Indexed keywords

DEXAMETHASONE; OVALBUMIN; PLACEBO; SALAZOSULFAPYRIDINE; SODIUM CHLORIDE;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BASEMENT MEMBRANE; CELL COUNT; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; ELECTRON MICROSCOPY; FEMALE; GOBLET CELL; HISTOLOGY; HISTOPATHOLOGY; LUNG; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; THICKNESS;

ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BASEMENT MEMBRANE; BRONCHI; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LUNG; MAST CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN; SPECIFIC PATHOGEN-FREE ORGANISMS; SULFASALAZINE;

EID: 53849145321     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140802271859     Document Type: Article

References (42)

1. Tagaya E, Tamaoki J: Mechanisms of airway remodeling in asthma. Allergol Int. 2007;56:33-340.
2. Kips JC, Pauwels RA: Airway wall remodelling: does it occur and what does it mean ? Clin Exp Allergy. 1999;29:1457-1466.
3. Sumi Y, Hamid Q: Airway remodeling in asthma. Allergol Int. 2007;56:341-348.
4. Payne DN, Rogers AV, Adelroth E, et al: Early thickening of the reticular basement in children with difficult asthma. Am J Respir Crit Care Med. 2003;167: 78-82.
5. Barnes PJ: Transcription factors in airway diseases. Lab Invest. 2006;86:867-872.
6. Christman JW, Sadikot RT, Blackwell TS: The role of nuclear factor-kappa B in pulmonary diseases. Chest. 2000;117:1482-1487.
7. Barnes PJ, Karin M: Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071.
8. Eddleston J, Herschbach J,Wagelie-Steffen AL, Christiansen SC, Zuraw BL: The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol. 2007;119:115-122.
9. Hart LA, Krishnan VL, Adcock IM, et al: Activation and localization of transcription factor, nuclear factor-kappa B in asthma. Am J Respir Crit Care Med. 1998;158:1585-1592.
10. Couëtil LL, Art T, de Moffarts B, et al: Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction. J Vet Intern Med. 2006;20:399-406.
11. Desmet C, Gosset P, Pajak B, et al: Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol. 2004;173:5766-5775.
12. Hancox RJ, Stevens DA, Adcock IM, et al: Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax. 1999;54:488-492.
13. Parry SD, Barbatzas C, Peel ET, Barton JR: Sulphasalazine and lung toxicity. Eur Respir J. 2002;19:756-764
14. Smedegard G, Bjork J. Sulfasalazine: mechanism of action in rheumatoid arthritis. Br J Rheumatol. 1995;34:7-15.
15. Haskó G, Szabó C, Németh ZH, Deitch EA: Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression. Immunology. 2001;103:473-478.
16. Wahl C, Liptay S, Adler G, Schmid RM: Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998;101:1163-1174.
17. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK: An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax. 1998;53:849-856.
18. Uzuner N, Kavukcu S, Yilmaz O, et al: The role of L-carnitine in treatment of a murine model of asthma. Acta Med Okayama. 2002;56:295-301.
19. Frode-Saleh TS, Calixto JB: Synergistic antiinflammatory effect of NF-kappaB inhibitors and steroidal or nonsteroidal antiinflammatory drugs in the pleural inflammation induced by carrageenan in mice. Inflamm Res. 2000;49:330-337.
20. Henderson WR Jr, Chiang GK, Tien YT, Chi EY: Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care. 2006;173:718-728.
21. Gadangi P, Longaker M, Naime D, et al: The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol. 1996;156:1937-1941.
22. Imai F, Suzuki T, Ishibashi T, Dohi Y: Effect of sulfasalazine on B cells. Clin Exp Rheumatol. 1991;9:259-264.
23. Stevens C, Lipman M, Fabry S, et al: Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells. J Pharmacol Exp Ther. 1995;272:399-406.
24. Bissonnette EY, Enciso JA, Befus AD: Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-α production by mast cells. J Immunol. 1996;156:218-223.
25. Aparicio-Pages MN, Verspaget HW, Hafkenscheid JC et al: Inhibition of cell-mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity. Gut. 1990;31:1030-1032.
26. Volin MV, Harlow LA, Woods JM, et al: Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicylic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum. 1999;42:1927-1935.
27. Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000;119:1209-1218.
28. Xu S, Xu Y, Zhang Z, Ni W, Chen S. Effect of nuclear factor-kappaB on airway remodeling in asthmatic rats. J Huazhong Univ Sci Technolog Med Sci. 2004;24:13-18.
29. Mauad T, Bel EH, Sterk PJ: Asthma therapy and airway remodeling. J Allergy Clin Immunol. 2007;120:997-1009.
30. Yamauchi K, Inoue H: Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling. Allergol Int. 2007;56:321-329.
31. Bourdin A, Neveu D, Vachier I, Paganin F, Godard P, Chanez P: Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol. 2007;119:1367-1374.
32. Zheng L, Howell SJ, Hatala DA, Huang K, Kem TS: Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes. 2007;56:337-345.
33. Menzies D, Nair A, Meldrum KT, Hopkinson P, Lipworth BJ: Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. J Allergy Clin Immunol. 2008;121:1184-1189.
34. Busse WW, Lemanske RF Jr: Asthma. N Engl J Med. 2001;344:350-362.
35. Chiang N, Arita M, Serhan CN: Anti-inflammatory circuitry: lipoxin, aspirin triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids. 2005;73:163-177.
36. Harmanci K. Montelukast: its role in the treatment of childhood asthma. Ther Clin Risk Manag. 2007;3:885-892.
37. Levy BD, De Sanctis GT, Devchand PR, et al: Multi-pronged inhibition of airway hyperresponsiveness and inflammation by lipoxin A(4). Nat Med. 2002;8:1018-1023.
38. Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994;265:956-959.
39. Perez GM, Melo M, Keegan AD, et al: Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J Immunol. 2002;168:1428-1434.
40. Chen LC, Kepka-Lenhart D, Wright TM, et al: Salicylate-enhanced activation of transcription factors induced by interferon-gamma. Biochem J. 1999;342:503-507.
41. Kurth T, Barr RG, Gaziano JM, Buring J: Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study. Thorax. 2008;63:514-518.
42. Barr RG, Kurth T, Stampfer MJ, Buring JE, Hennekens CH, Gaziano JM: Aspirin and decreased adult-onset asthma: randomized comparisons from the physicians health study. Am J Respir Crit Care Med. 2007;175:120-125.